Biocompatibility Studies of Hemoperfusion Systems for Liver and Kidney Support
The biocompatibility of liver and kidney support hemoperfusion systems operating in-vitro with blood taken from a number of donors was investigated. The liver support system, aimed at the specific removal of Bilirubin, consisted of a column of Dowex 1X2 beads coated with an Acrylic polymer and a crosslinked Albumin. The kidney support system, aimed at the specific removal of phosphate ions, consisted of a packed-bed of alumina particles coated with a modified collodion. Comparison tests with empty columns show that the adsorbents do not significantly affect the depletion of erythrocytes leukocytes and thrombocytes.
KeywordsAlumina Particle Liver Support Large Platelet Liver Support System Empty Column
Unable to display preview. Download preview PDF.
- 2.Sideman, S., Mor, L., Rousseau, I., Brandes, J.M. and Ben-Arie, D., “Removal of Bilirubin from the Blood of Jaundiced Infants”, Proc. 2nd Strathclyde Bioengineering Seminar — “Artificial organs”, (1976), Kenedi, Courtney, Gaylor and Gilchrist, eds., MacMillan Press, London 1977.Google Scholar
- 3.Winchester, J.F., MacKay, J.M., Forbes, C.D., Blakely, E., Prentice, C.R.M. and Kennedy, A.C. “Haemostatic Changes Induced in-vitro by Activated Charcoal Haemoperfusion”, Thromb.Diath., 34(2), 587, (1975).Google Scholar
- 4.Scharschmidt, B.F., Martin, J.F., Shapiro, L.J., Plotz, P.H. and Berk, P.D., “Use of calcium chelating agents and prostaglandin E1(PGE1) to eliminate platelet losses during hemoperfusion through various adsorbents”, Gastroentr. 69 (3), 864, (1975).Google Scholar
- 6.Williams, R., “Approaches to the development of artificial liver support”, Proc.2nd Strathclyde Bioengineering Seminar — “Artificial organs”, (1976), Kenedi, Courtney, Gaylor and Gilchrist, eds., MacMillan Press, London, 1977.Google Scholar
- 7.Hoffer, E., Rousseau, I., Sideman, S., Better, O. and Raziel, A, “Selective removal of waste metabolites from human serum”, Proc.XXIV International Symposium on macromolecules; Jerusalem, July 1975.Google Scholar
- 8.Sideman, S., Hoffer, E., Better, O. and Lupovitch, S, “Selective removal of phosphate ions from the blood of uremic patients”, Proc. 2nd Strathclyde Bioengineering Seminar — “Artificial Organs”, (1976), Kenedi, Courtney, Gaylor & Gilchrist, eds., MacMillan Press, London, 1977.Google Scholar
- 9.Yaniv, A, “Removal of waste metabolites from the blood serum -inorganic phosphate”, M.Sc. Thesis (in Hebrew) Technion, Haifa, August, 1976.Google Scholar
- 10.Ramon, O, “Selective removal of metabolites from the blood serum by hemoperfusion”, M.Sc. Thesis (in Hebrew), Technion, Haifa, Aug.1976.Google Scholar
- 12.Nishizawa, E.E., Wynalda, D.J. and Lednicer, D, “Non-thrombogenic surface with Evan’s blue”, “Platelets, Thrombosis and Inhibitors”, P. Didisheim, T. Shimamoto and H. Yamazaki, eds., p.135, F.K. Shattauer Verlag, 1974.Google Scholar
- 13.de Leval, M.R., Hill, J.D., Mielke, C.H., Macur, M.F. and Gerbode, F. “Blood platelets and extracorporeal circulation”, J.Thor.Cardiovas. Surg., 69, 144 (1975).Google Scholar
- 14.Vale, J.A., Rees, A.J., Widdop, B. and Goulding, R. “The use of charcoal hemoperfusion in the management of severely poisoned patients”, in “Artif. Liver Support”, p.352, R. Williams and I.M. Murray Lyon, eds., Pitman Medical Publishing Co., 1975.Google Scholar